These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 34768317)

  • 1. Combination therapy of calcitriol inhibits the proliferation of breast cancer cells: new concept of nonclassical function of calcitriol.
    Aljunidee KA; Bardaweel SK
    Horm Mol Biol Clin Investig; 2021 Nov; 43(2):199-205. PubMed ID: 34768317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular and Metabolomic Investigation of Celecoxib Antiproliferative Activity in Mono-and Combination Therapy against Breast Cancer Cell Models.
    Bardaweel SK; Dahabiyeh LA; Akileh BM; Shalabi DD; AlHiary AK; Pawling J; Dennis JW; Rahman AMA
    Anticancer Agents Med Chem; 2022; 22(8):1611-1621. PubMed ID: 34515014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proton pump inhibitors enhance chemosensitivity, promote apoptosis, and suppress migration of breast cancer cells.
    Ihraiz WG; Ahram M; Bardaweel SK
    Acta Pharm; 2020 Jun; 70(2):179-190. PubMed ID: 31955147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined Raloxifene and Letrozole for Breast Cancer Patients.
    Vohora D; Kalam A; Leekha A; Talegaonkar S; Verma AK
    Arch Med Res; 2017 Aug; 48(6):561-565. PubMed ID: 29229198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiproliferative and antimetastatic characterization of an exo-heterocyclic androstane derivative against human breast cancer cell lines.
    Kulmány ÁE; Frank É; Kovács D; Kirisits K; Krupitza G; Neuperger P; Alföldi R; Puskás LG; Szebeni GJ; Zupkó I
    Biomed Pharmacother; 2021 Aug; 140():111728. PubMed ID: 34020244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apoptosis induction in human breast cancer cell lines by synergic effect of raloxifene and resveratrol through increasing proapoptotic genes.
    Mirzapur P; Khazaei MR; Moradi MT; Khazaei M
    Life Sci; 2018 Jul; 205():45-53. PubMed ID: 29705353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Ruxolitinib and Calcitriol Combination Treatment on Various Molecular Subtypes of Breast Cancer.
    Schneider J; Jeon YW; Suh YJ; Lim ST
    Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The enhanced antiproliferative response to combined treatment of trichostatin A with raloxifene in MCF-7 breast cancer cells and its relevance to estrogen receptor β expression.
    Tu Z; Li H; Ma Y; Tang B; Tian J; Akers W; Achilefu S; Gu Y
    Mol Cell Biochem; 2012 Jul; 366(1-2):111-22. PubMed ID: 22476901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcitriol and its analogues enhance the antiproliferative activity of gefitinib in breast cancer cells.
    Segovia-Mendoza M; Díaz L; González-González ME; Martínez-Reza I; García-Quiroz J; Prado-Garcia H; Ibarra-Sánchez MJ; Esparza-López J; Larrea F; García-Becerra R
    J Steroid Biochem Mol Biol; 2015 Apr; 148():122-31. PubMed ID: 25510900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Debio-0932, a second generation oral Hsp90 inhibitor, induces apoptosis in MCF-7 and MDA-MB-231 cell lines.
    Özgür A; Kara A; Gökşen Tosun N; Tekin Ş; Gökçe İ
    Mol Biol Rep; 2021 Apr; 48(4):3439-3449. PubMed ID: 33999319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular effect of styrene substituted biscoumarin caused cellular apoptosis and cell cycle arrest in human breast cancer cells.
    Perumalsamy H; Sankarapandian K; Kandaswamy N; Balusamy SR; Periyathambi D; Raveendiran N
    Int J Biochem Cell Biol; 2017 Nov; 92():104-114. PubMed ID: 28958615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic anticancer effects of ruxolitinib and calcitriol in estrogen receptor‑positive, human epidermal growth factor receptor 2‑positive breast cancer cells.
    Lim ST; Jeon YW; Gwak H; Kim SY; Suh YJ
    Mol Med Rep; 2018 Apr; 17(4):5581-5588. PubMed ID: 29436642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Combined Treatment with Vitamin D and COX2 Inhibitors on Breast Cancer Cell Lines.
    Friedrich M; Reichert K; Woeste A; Polack S; Fischer D; Hoellen F; Rody A; Köster F; Thill M
    Anticancer Res; 2018 Feb; 38(2):1201-1207. PubMed ID: 29374758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-Cancer Effects of Epigenetics Drugs Scriptaid and Zebularine in Human Breast Adenocarcinoma Cells.
    Yap ZH; Kong WY; Azeez AR; Fang CM; Ngai SC
    Anticancer Agents Med Chem; 2022; 22(8):1582-1591. PubMed ID: 34102995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcitriol enhances the effect of photodynamic therapy in human breast cancer.
    Peng Z; Liu R; Li Y; Zhang Q; Cai X; Li L
    J BUON; 2016; 21(5):1068-1075. PubMed ID: 27837606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thieno[2,3-d]pyrimidin-4(3H)-one Derivatives of Benzimidazole as Potential Anti- Breast Cancer (MDA-MB-231, MCF-7) Agents.
    Dimov S; Mavrova AT; Yancheva D; Nikolova B; Tsoneva I
    Anticancer Agents Med Chem; 2021; 21(11):1441-1450. PubMed ID: 32698751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apoptotic action of 17beta-estradiol in raloxifene-resistant MCF-7 cells in vitro and in vivo.
    Liu H; Lee ES; Gajdos C; Pearce ST; Chen B; Osipo C; Loweth J; McKian K; De Los Reyes A; Wing L; Jordan VC
    J Natl Cancer Inst; 2003 Nov; 95(21):1586-97. PubMed ID: 14600091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory effects of mild hyperthermia plus docetaxel therapy on ER(+/-) breast cancer cells and action mechanisms.
    Lv F; Yu Y; Zhang B; Liang D; Li ZM; You W
    J Huazhong Univ Sci Technolog Med Sci; 2013 Dec; 33(6):870-876. PubMed ID: 24337851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the potential anticancer activity of different vitamin D metabolites on colorectal and breast cancer cell lines.
    Khriesha A; Bustanji Y; Abu Farha R; Al-Abbasi R; Abu-Irmaileh B
    Horm Mol Biol Clin Investig; 2021 Feb; 42(1):3-9. PubMed ID: 33544505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of the polyamine catabolic enzymes SSAT and SMO in the synergistic effects of standard chemotherapeutic agents with a polyamine analogue in human breast cancer cell lines.
    Pledgie-Tracy A; Billam M; Hacker A; Sobolewski MD; Woster PM; Zhang Z; Casero RA; Davidson NE
    Cancer Chemother Pharmacol; 2010 May; 65(6):1067-81. PubMed ID: 19727732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.